Advertisement
Organisation › Details
Almirall (Group)
Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient’s needs through science to improve their lives. Our Noble Purpose is at the core of our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. The company, founded in 1943 and headquartered in Barcelona, is publically traded on the Spanish Stock Exchange and is a member of the IBEX 35 (ticker: ALM). Throughout its 77-year history, Almirall has retained a strong focus on the needs of patients. Currently, Almirall has a direct presence in 21 countries and strategic agreements in over 70, through 13 subsidiaries, with about 1,800 employees. Total revenues in 2019 were 908.4 million euros. *
Start | 0943-01-01 established | |
Industry | pharmaceutical | |
Industry 2 | dermatic | |
Region | Barcelona | |
Country | Spain (España) | |
Street | 151 Ronda General Mitre | |
City | 08022 Barcelona | |
Tel | +34-932-913-000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | F: 1,001 to 5,000 (2021-02-03) |
Currency | EUR | |
Annual sales | 908,400,000 (revenues, total, consolidated (2019) 2019-12-31) | |
Profit | 106,000,000 (2019-12-31) | |
Cash | 117,400,000 (2019-12-31) | |
* Document for »About Section«: Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Almirall (Group)
- [1] Evotec SE. (5/19/22). "Press Release: Evotec and Almirall Enter into a Multi-target Alliance in Medical Dermatology". Hamburg & Barcelona....
- [2] Almirall S.A.. (12/14/21). "Press Release: Ichnos Sciences and Almirall Enter into a Licensing Agreement for First-in-Class IL-1RAP Antagonist Monoclonal Antibody". New York, NY & Barcelona....
- [3] Evotec AG. (9/17/18). "Press Release: Evotec and Almirall Enter into Research Collaboration in the Field of Dermatiological Diseases". Hamburg & Barcelona....
- [4] Locust Walk Partners, LLC. (7/11/18). "Press Release: Locust Walk Appoints Lubor Gaal as Senior Vice President and Head of Europe to Further Advance Global Expansion of Transactions Business". London & Boston, MA....
- [5] Almirall S.A.. (8/28/17). "Press Release: Almirall Appoints Peter Guenter as New CEO". Barcelona....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top